Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
about
Rapid antidepressant effects: moving right alongEvaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strainsBrain-derived neurotrophic factor: role in depression and suicideNeurobiology of depression: an integrated view of key findingsBrain Structural Effects of Antidepressant Treatment in Major DepressionTargeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateSignal transduction and genes-to-behaviors pathways in psychiatric diseasesNeurobiology of mood, anxiety, and emotions as revealed by studies of a unique antidepressant: tianeptinePharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug responseNew approaches to antidepressant drug discovery: beyond monoaminesNovel sigma (sigma) receptor agonists produce antidepressant-like effects in miceSynergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibitionAdvances in the treatment of anxiety: targeting glutamate.How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.Stress sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram.Knockout of the norepinephrine transporter and pharmacologically diverse antidepressants prevent behavioral and brain neurotrophin alterations in two chronic stress models of depression.Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms.Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.Effect of ovarian hormones on genes promoting dendritic spines in laser-captured serotonin neurons from macaquesImplications of adult hippocampal neurogenesis in antidepressant action.Efficacy and tolerability of agomelatine in the treatment of depressionEffects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats.From synapse to nucleus: novel targets for treating depression.Physical Activity Modulates Common Neuroplasticity Substrates in Major Depressive and Bipolar Disorder.The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats.Review: magnetic resonance spectroscopy studies of pediatric major depressive disorderGABAergic neurons in nucleus accumbens are correlated to resilience and vulnerability to chronic stress for major depression.Aging changes and medical complexity in late-life bipolar disorder: emerging research findings that may help advance care.A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors.Antipsychotic-induced gene regulation in multiple brain regions.Mifepristone prevents stress-induced apoptosis in newborn neurons and increases AMPA receptor expression in the dentate gyrus of C57/BL6 miceOvarian steroids increase glutamatergic related gene expression in serotonin neurons of macaques.Ovarian steroids increase spinogenetic proteins in the macaque dorsal raphe.Effect of ovarian steroids on gene expression related to synapse assembly in serotonin neurons of macaques.Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjectsDendritic morphology of hippocampal and amygdalar neurons in adolescent mice is resilient to genetic differences in stress reactivity.The role of BDNF as a mediator of neuroplasticity in bipolar disorder.Enhancing AMPA to NMDA throughput as a convergent mechanism for antidepressant action.Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.
P2860
Q24614410-0FCEBCCF-2CC6-4031-B515-6AD1C8A0B8EAQ24632901-0C1F745C-9D93-49EB-9DB3-224BB9A0C20AQ24647110-257461DB-4B89-4957-91F4-A9B22605820FQ24655216-30B1430C-B4E2-4AE1-8827-53709872DB86Q26786239-89122A91-B963-4FCF-A3FA-DB6BC039E4ABQ27004490-47C5F856-B831-4B5A-BDCF-518C3AF22096Q28182063-96664505-3B0F-4D70-B8C0-7DEE3C173AF1Q28238686-8DE88E60-372B-4F17-812E-4174EC087C4FQ28252209-6312FE47-5B05-4EEC-9A7D-8D3A1BB0010BQ28293089-8B3F6369-F9DE-48D7-B3C9-6C996B98B628Q28294148-726D6D4C-FC68-4080-BCC0-43A3D7A7F19FQ28468536-88218FE7-E0F0-464E-BFA2-FB49E47C0786Q30457479-5E4DF3E2-A233-47F8-8CE5-7DBD94FC81D4Q30485725-C3A34B73-04E6-4D75-A43E-331739D777ECQ30490951-4D6AE688-65C4-4673-984C-51A65718DE4DQ30491061-A0378E73-7BE5-41DD-A4ED-075EB21B93D9Q31156853-99AE77D6-068B-4860-B215-2683854D80C1Q33429548-B7A014F8-5C0D-426F-80A9-844E3D3BC23EQ33494309-E66314A9-F515-473E-852E-99EF609079ACQ33553686-0DCC720E-D4EE-4DC0-BEB9-3FCA7EEF722DQ33583450-BA059891-1D5A-4A47-8F41-EE3369C00103Q33624583-EABCED2F-8372-4FF2-86EA-36603E69851AQ33653177-2A4071D9-BBC7-401C-82C1-8E8C41C71367Q33655590-DD747AA3-795A-4F1E-A5A6-69EC2070F570Q33712487-9A2B993A-8C17-47FD-B0E5-8656550CD935Q33783427-4A471D1B-84BA-43AE-979D-DBC0AD91AAB2Q33829363-544514B1-0805-493B-B468-B9A230687574Q33835333-994B2E98-C4B1-4F88-BBBE-332F763913C0Q33953387-4EF07A40-0489-4482-A8D3-90C4B3C1CD47Q34066954-527E1106-E486-4840-ABEB-C768F628B423Q34091504-65181E4A-770D-4C6E-A098-2A7060969697Q34095573-06B38381-60A7-48EC-8F75-98CE21191E2DQ34161343-CD87A96C-B381-4E98-ACF2-0ECC3DC3E0ABQ34192562-56AC6502-4FD7-4634-B665-47D6ACC37978Q34254887-A4409CEC-EF31-4D18-B467-EEC93E624F58Q34305851-1EE6F06A-1741-4337-919E-DB02D16845D6Q34497541-003A7A85-0DF4-4CA6-8E5A-1D3F37B770F6Q34522617-9B89AE09-0764-495D-8C8F-5172EC0D394CQ34621808-D20C76DF-DC18-49E7-ACE4-E518C03EB783Q34655680-1868C226-6D1B-4A3C-9957-8B59680E511C
P2860
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Enhancing neuronal plasticity ...... difficult-to-treat depression.
@ast
Enhancing neuronal plasticity ...... difficult-to-treat depression.
@en
type
label
Enhancing neuronal plasticity ...... difficult-to-treat depression.
@ast
Enhancing neuronal plasticity ...... difficult-to-treat depression.
@en
prefLabel
Enhancing neuronal plasticity ...... difficult-to-treat depression.
@ast
Enhancing neuronal plasticity ...... difficult-to-treat depression.
@en
P2093
P1476
Enhancing neuronal plasticity ...... difficult-to-treat depression.
@en
P2093
Carlos A Zarate
Dennis S Charney
Husseini K Manji
Jennifer L Payne
Jonathan Sporn
Jorge A Quiroz
Kirk Denicoff
Neil A Gray
P304
P356
10.1016/S0006-3223(03)00117-3
P407
P577
2003-04-01T00:00:00Z